Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.3%

1 terminated/withdrawn out of 44 trials

Success Rate

96.9%

+10.4% vs industry average

Late-Stage Pipeline

16%

7 trials in Phase 3/4

Results Transparency

0%

0 of 31 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
20(66.7%)
Phase 3
5(16.7%)
Phase 1
2(6.7%)
Phase 4
2(6.7%)
Early Phase 1
1(3.3%)
30Total
N/A(20)
Phase 3(5)
Phase 1(2)
Phase 4(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (44)

Showing 20 of 44 trials
NCT05361486Completed

Radical Cure (RC) With Tafenoquine or Primaquine After Semi-quantitative G6PD Testing: A Feasibility Study in Peru

Role: collaborator

NCT05879224Not ApplicableCompleted

Short Course Primaquine for the Radical Cure of P. Vivax Malaria - Indonesia

Role: collaborator

NCT04240990Not ApplicableCompleted

Development of a Diagnostic Prediction Score for Tuberculosis in Hospitalized Children With Severe Acute Malnutrition (TB-Speed SAM)

Role: collaborator

NCT05874271Not ApplicableCompleted

Short Course Primaquine for the Radical Cure of P. Vivax - Papua New Guinea

Role: collaborator

NCT03831906Not ApplicableCompleted

Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia)

Role: collaborator

NCT06129916Not Yet Recruiting

Assessing the Acceptability, Feasibility, Effectiveness and Cost-effectiveness of LADB

Role: collaborator

NCT06395129Recruiting

Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries

Role: collaborator

NCT05133661Active Not Recruiting

SUCCESS - Feasibility of HPV Testing and Treatment of Pre-cancerous Cervical Cancer Lesions (HPV Study)

Role: collaborator

NCT06159504Early Phase 1Recruiting

Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania

Role: collaborator

NCT04121026Not ApplicableCompleted

Validation of a Tuberculosis Treatment Decision Algorithm in HIV-infected Children (TB-Speed HIV)

Role: collaborator

NCT04038632Not ApplicableCompleted

Impact of an Innovative Childhood TB Diagnostic Approach Decentralized to District Hospital and Primary Health Care Levels on Childhood Tuberculosis Case Detection and Management in High Tuberculosis Incidence Countries (TB-Speed Decentralisation)

Role: collaborator

NCT04966702Phase 3Completed

Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA)

Role: collaborator

NCT05562609Phase 3Recruiting

Tranexamic Acid to Prevent Heavy Bleeding After Childbirth in Women At Higher Risk

Role: collaborator

NCT03249181Phase 3Completed

Dolutegravir in Pregnant HIV Mothers and Their Neonates

Role: collaborator

NCT03931473Not ApplicableCompleted

Efficacy of Two Dual Active Ingredient Long Lasting Insecticidal Nets for Control of Malaria Transmitted by Pyrethroid Resistant Vectors in Benin

Role: collaborator

NCT04203628Not ApplicableCompleted

Evaluation of Four Stool Processing Methods Combined With Xpert MTB/RIF Ultra for Diagnosis of Intrathoracic Paediatric TB (TB-Speed - Stool Processing)

Role: collaborator

NCT06203925Unknown

Hepatitis C Virus Self-testing (HCVST) in Sexual and Gender Minorities in Rio de Janeiro

Role: collaborator

NCT05382130Not ApplicableCompleted

INTEGrating Ag-RDTs for COVID-19 in MNCH,HIV and TB Services in Cameroon and Kenya

Role: collaborator

NCT05498727Completed

Evaluation of the Integration of Ag-RDTs for COVID-19 in MNCH, HIV and TB Services in Cameroon and Kenya

Role: collaborator

NCT05529771Completed

Clinical Outcomes of paTients pREsenting to HArare COVID-19 CenTer of Excellence With SARS-CoV-2 Infection

Role: collaborator